Kirin to Acquire Jamieson Wellness
August 6, 2026
Kirin Holdings agreed to acquire all outstanding shares of Jamieson Wellness for C$45.75 per share in cash, valuing the company at approximately C$2.0 billion in equity and C$2.5 billion in enterprise value. The acquisition is intended to expand Kirin’s Health Science business into North America and establish Jamieson as a platform for further regional growth; shareholder and final court approvals have been obtained, while regulatory clearances and other closing conditions remain outstanding.
- Buyers
- Kirin Holdings Company, Limited
- Targets
- Jamieson Wellness Inc.
- Industry
- Consumer Products
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Jasper Therapeutics Acquires Kira Pharmaceuticals in All-Stock Merger
July 16, 2026
Biotechnology
Jasper Therapeutics has completed the acquisition of Kira Pharmaceuticals in an all-stock transaction, forming a combined company focused on advancing a consolidated immunology pipeline. Concurrent with the deal, Jasper arranged a $132 million private placement and Kira out-licensed KP-301 and KP-402 to Mirador Therapeutics for $12 million upon signing, with potential development and sales milestones.
-
Grünenthal Acquires Kyowa Kirin’s 49% Stake in Grünenthal Meds JV
March 2, 2026
Pharmaceuticals
Grünenthal acquired Kyowa Kirin International’s 49% stake in Grünenthal Meds, taking full ownership of the joint venture created in 2023 to market Grünenthal’s established medicines portfolio. The JV manages a portfolio of 12 established brands across six therapeutic areas and more than 60 markets, with key products including Abstral, PecFent, Moventig, and Adcal-D3.
-
Kyowa Kirin Acquires Orchard Therapeutics
October 5, 2023
Biotechnology
Kyowa Kirin Co., Ltd. agreed to acquire Orchard Therapeutics plc for $16.00 per ADS in cash plus a $1.00 contingent value right (CVR), representing a potential total equity value of approximately $477.6 million. The acquisition gives Kyowa Kirin a leading HSC gene therapy platform and commercial asset Libmeldy, accelerating development and commercialization of Orchard's rare-disease gene therapies.
-
Jamieson Wellness Acquires Distribution Operating Assets in China
May 4, 2023
Consumer Products
Jamieson Wellness Inc. completed the previously announced acquisition of operating assets from its distribution partner in China for approximately CAD 26 million, giving the company full value-chain ownership in the market. The move enables Jamieson to operate sales, marketing and distribution directly in China as it pursues growth; a previously announced partnership with DCP Capital to support expansion in China is expected to close shortly.
-
Jamieson Wellness Acquires Nutrawise (youtheory) for ~US$210M
July 19, 2022
Consumer Products
Jamieson Wellness Inc. has completed the acquisition of Nutrawise Health & Beauty Corporation, owner of the youtheory brand, for approximately US$210 million plus contingent consideration. The deal gives Jamieson a U.S. platform and premium supplement brand to accelerate expansion in the large U.S. vitamins, minerals and supplements (VMS) market and is immediately accretive to pro forma 2022 revenues and EBITDA.
-
Ayr Wellness Acquires Herbal Remedies Dispensaries, LLC
July 20, 2021
Retail
Ayr Wellness Inc. agreed to acquire 100% of Herbal Remedies Dispensaries, LLC, an operator of two licensed retail cannabis dispensaries in Quincy, Illinois, for total consideration of $30 million (comprised of $10 million in stock, $12 million in seller notes and $8 million in cash). The acquisition adds roughly 50 employees, expands Ayr into its eighth state (Illinois), is expected to close in Q4 2021 and is subject to customary regulatory approvals.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.